Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference57 articles.
1. European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update;Babjuk;Eur Urol,2019
2. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus Calmette-Guérin;Cambier;Eur Urol,2016
3. Intravesical bacillus Calmette-Guerinreduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;RJ;J Urol,2002
4. maintenance bacillus calmette-guerin immunotherapy for recurrent ta, t1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study;Lamm;j urol,2000
5. Association between number of endoscopic resections and utilization of bacillus Calmette-Guérin therapy for patients with high-grade, non–muscle-invasive bladder cancer;Lenis;Clin Genitourin Cancer,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer;Current Opinion in Urology;2023-06-30
2. Cistectomía radical asistida por robot vs. cistectomía radical abierta: revisión sistemática de ensayos controlados aleatorizados;Actas Urológicas Españolas;2023-06
3. Robot-assisted vs. open radical cystectomy: systematic review and meta-analysis of randomized controlled trials;Actas Urológicas Españolas (English Edition);2023-06
4. Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review;Minerva Urology and Nephrology;2023-05
5. Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study;Journal of Urology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3